Anbio Biotechnology (NNNN) Receivables (2023 - 2025)

Historic Receivables for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $3716.4 billion.

  • Anbio Biotechnology's Receivables changed N/A to $3716.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $3716.4 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 4351.11% down from last year.
  • As of Q2 2025, Anbio Biotechnology's Receivables stood at $3716.4 billion.
  • In the past 5 years, Anbio Biotechnology's Receivables registered a high of $3716.4 billion during Q2 2025, and its lowest value of $1.9 million during Q4 2023.
  • Its 3-year average for Receivables is $1593.7 billion, with a median of $1064.8 billion in 2024.
  • Data for Anbio Biotechnology's Receivables shows a peak YoY increase of 5648884406.25% (in 2024) and a maximum YoY decrease of 5648884406.25% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Anbio Biotechnology's Receivables stood at $1.9 million in 2023, then soared by 56488844.06% to $1064.8 billion in 2024, then skyrocketed by 249.02% to $3716.4 billion in 2025.
  • Its last three reported values are $3716.4 billion in Q2 2025, $1064.8 billion for Q4 2024, and $1.9 million during Q4 2023.